عنوان

Economic evaluation of cancer drugs :

(Number (ISBN

0429155824

(Number (ISBN

0429531842

(Number (ISBN

0429546548

(Number (ISBN

1498761313

(Number (ISBN

9780429155826

(Number (ISBN

9780429531842

(Number (ISBN

9780429546549

(Number (ISBN

9781498761314

Erroneous ISBN

1498761305

Erroneous ISBN

9781498761307

Title Proper

Economic evaluation of cancer drugs :

General Material Designation

[Book]

Other Title Information

using clinical trial and real-world data /

First Statement of Responsibility

Iftekhar Khan, Ralph Crott, Zahid Bashir.

Place of Publication, Distribution, etc.

Boca Raton, FL :

Name of Publisher, Distributor, etc.

Chapman and Hall/CRC,

Date of Publication, Distribution, etc.

[2020]

Specific Material Designation and Extent of Item

1 online resource.

Series Title

Chapman & Hall/CRC biostatistics series

Text of Note

Includes bibliographical references and index.

Text of Note

Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization. Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.

Source for Acquisition/Subscription Address

Taylor & Francis

Stock Number

9780429155826

Title

Economic evaluation of cancer drugs

International Standard Book Number

9781498761307

International Standard Book Number

9780429531842

Antineoplastic agents-- Development-- Economic aspects.

Clinical trials-- Economic aspects.

Medical economics.

Antineoplastic Agents-- economics.

Clinical Trials as Topic.

Cost-Benefit Analysis.

Drug Development-- economics.

Models, Economic.

HEALTH & FITNESS / Diseases / General.

MATHEMATICS / Probability & Statistics / General

MEDICAL / Clinical Medicine.

MEDICAL / Diseases.

MEDICAL / Epidemiology

MEDICAL / Evidence-Based Medicine.

MEDICAL / Internal Medicine.

MEDICAL / Pharmacology

Medical economics.

HEA-- 039000

MAT-- 029000

MBNS

MED-- 014000

MED-- 022000

MED-- 028000

MED-- 045000

MED-- 071000

MED-- 112000

Number

Edition

Class number

Class number

Class number

Khan, Iftekhar, (Statistician)

Bashir, Zahid

Crott, Ralph

Date of Transaction

20200823040147.0

Cataloguing Rules (Descriptive Conventions))

rda

Electronic name

[Book]

Y